SMV displays solve vergence–accommodation conflict

A conflict between accommodation and vergence is one possible cause of visual fatigue and discomfort while viewing conventional three-dimensional (3D) displays. Previous studies have proposed the super multi-view (SMV) display technique to solve the vergence-accommodation conflict, in which two or more parallax images enter the pupil of the eye with highly directional rays. We simultaneously measured accommodative, vergence and pupillary responses to SMV 3D displays to examine whether they can reduce the conflict. For comparison, responses to two-view stereo images and real objects were also measured. The results show that the range of the accommodative response was increased by the SMV images compared with the two-view images. The slope of the accommodation-vergence response function for the SMV images was similar to that for the real objects rather than the two-view images. We also found that enhancement of the accommodative range by the SMV images is noticeable with binocular viewing, indicating that vergence-induced accommodation plays an important role in viewing SMV displays. These results suggest that SMV displays induced a more natural accommodative response than did conventional, two-view stereo displays. As a result, SMV displays reduced the vergence-accommodation conflict

Multiwavelength Digital Holography and Phase-Shifting Interferometry Selectively Extracting Wavelength Information: Phase-Division Multiplexing (PDM) of Wavelengths

In this chapter, we introduce multiwavelength digital holographic techniques and a novel multiwavelength imaging technique. General multiwavelength imaging systems adopt temporal division, spatial division, or space-division multiplexing to obtain wavelength information. Holographic techniques give us unique multiwavelength imaging systems, which utilize temporal or spatial frequency-division multiplexing. Conventional multiwavelength digital holography systems have been combined with one of the methods listed above. We have proposed phase-shifting interferometry selectively extracting wavelength information, characterized as a multiwavelength three-dimensional (3D) imaging technique based on holography and called phase-division multiplexing (PDM) of multiple wavelengths. In PDM, wavelength-multiplexed phase-shifted holograms are recorded, and multiwavelength information is separately extracted from the holograms in the space domain. Phase shifts are introduced for respective wavelengths to separate object waves with multiple wavelengths in the polar coordinate plane, and multiple object waves are selectively extracted by the signal processing based on phase-shifting interferometry. Additionally, the system of equations needed to obtain a multiwavelength 3D image is solved with less wavelength-multiplexed images using two-step phase-shifting interferometry-merged phase-division multiplexing (2π-PDM), which makes the best use of 2π ambiguity of the phase and two-step phase-shifting method. The PDM techniques are reviewed and color 3D imaging ability is described with numerical and experimental results

Eradication of Hepatitis C Virus Subgenomic Replicon by Interferon Results in Aberrant Retinol-Related Protein Expression

Hepatitis C virus (HCV) infection induces several changes in hepatocytes, such as oxidative stress, steatosis, and hepatocarcinogenesis. Although considerable progress has been made during recent years, the mechanisms underlying these functions remain unclear. We employed proteomic techniques in HCV replicon-harboring cells to determine the effects of HCV replication on host-cell protein expression. We examined two-dimensional electrophoresis (2-DE) and mass spectrometry to compare and identify differentially expressed proteins between HCV subgenomic replicon-harboring cells and their “cured” cells. One of the identified proteins was confirmed using enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. Full-length HCV genome RNA replicating and cured cells were also assessed using ELISA. Replicon-harboring cells showed higher expression of retinal dehydrogenase 1 (RALDH-1), which converts retinol to retinoic acid, and the cured cells showed higher expression of retinol-binding protein (RBP), which transports retinol from the liver to target tissues. The alteration in RBP expression was also confirmed by ELISA and Western blot analysis. We conclude that protein expression profiling demonstrated that HCV replicon eradication affected retinol-related protein expression

A homosexual japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis

We report herein a case with acute hepatitis due to hepatitis B virus genotype Ae, concurrent with amebic colitis. A 39-year-old homosexual Japanese man was admitted to our hospital with jaundice. Laboratory tests showed an elevation of transaminase and positivity for hepatitis B surface antigen and IgM-type antibody to hepatitis B core antigen. The hepatitis B virus genotype was determined to be Ae. Furthermore, a mud-like stool with blood and mucous had sometimes been noted during the past 3 years, and amebic colitis was shown by colonofi berscopy during hospitalization. The patient was diagnosed with acute hepatitis B, concurrent with amebic colitis, and was successfully treated with lamivudine and metronidazole. In Japanese patients with acute hepatitis B virus genotype A infection, homosexual activity tends to be high. Furthermore, in Japanese homosexual men, amebiasis has been increasing. Thus, in Japanese patients with acute hepatitis B, a determination of genotype should be performed in order to investigate the route of transmission of hepatitis B virus, and a search for amebiasis should be performed in patients with acute hepatitis due to hepatitis B virus genotype A. Furthermore, education of homosexual men regarding hepatitis B virus, hepatitis B virus vaccination, and amebiasis is urgently required

Bridging-arylene effects on spectroscopic and photophysical properties of arylborane–dipyrrinato zinc(ii) complexes

Novel bis(dipyrrinato)zinc(ii) derivatives having 4-[bis(2,4,6-trimethylphenyl)boryl]phenyl (ZnBph) or 4-[bis(2,4,6-trimethylphenyl)boryl]-2,3,5,6-tetramethylphenyl groups (ZnBdu) at the 5-position of the dipyrrinato ligands were designed and synthesized.InZnBphwith the smaller dipyrrinate-arylene and arylene-dimesitylboryl dihedral angles, an intramolecular charge transfer arising from the presence of the vacant p orbital on the boron atom participates in the ππ* excited state in character in contrast to the pure ππ* excited state ofZnBdu. The synergistic ππ*/ILCT excited state was weakly fluorescent, and the fluorescence was enhanced upon binding of fluoride to the boron atom

Complete set of polarization transfer observables for the 16O(p⃗,n⃗)16F{}^{16}{\rm O}(\vec{p},\vec{n}){}^{16}{\rm F} reaction at 296 MeV and 0 degrees

We report measurements of the cross section and a complete set of polarization transfer observables for the ${}^{16}{\rm O}(\vec{p},\vec{n}){}^{16}{\rm F}$ reaction at a bombarding energy of $T_p$ = 296 MeV and a reaction angle of $\theta_{\rm lab}$ = $0^{\circ}$. The data are compared with distorted-wave impulse approximation calculations employing the large configuration-space shell-model (SM) wave functions. The well-known Gamow-Teller and spin-dipole (SD) states at excitation energies of $E_x$ $\lesssim$ 8 MeV have been reasonably reproduced by the calculations except for the spin--parity $J^{\pi}$ = $2^-$ state at $E_x$ = 5.86 MeV. The SD resonance at $E_x$ $\simeq$ 9.5 MeV appears to have more $J^{\pi}$ = $2^-$ strength than $J^{\pi}$ = $1^-$ strength, consistent with the calculations. The data show significant strength in the spin-longitudinal polarized cross section $ID_L(0^{\circ})$ at $E_x$ $\simeq$ 15 MeV, which indicates existence of the $J^{\pi}$ = $0^-$ SD resonance as predicted in the SM calculations.Comment: 6 figures, submitted to Physical Review

Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease

For patients with chronic hepatitis due to hepatitis B virus (HBV), factors predicting hepatocellular carcinoma (HCC) other than high levels of HBV-DNA and alanine aminotransferase (ALT) are needed to prevent HCC development, as many patients with chronic HBV infection fulfill these conditions. The purpose of this study was to clarify factors predictive of HCC development for those patients. The study was a systematic cohort analysis of 303 consecutive patients with hepatitis B e-antigen, receiving laparoscopic examination for assessment of liver disease. Laparoscopic, histological, and clinical characteristics were investigated as related to HCC development. HCC occurred in 27 patients during a mean follow-up of 8.0 +/- A 5.0 years, at the age of 37-72 years. Significant associations with HCC development were shown for liver cirrhosis, histological activity grade, reddish markings, and older age. Multivariate analysis revealed that HCC development was strongly associated with older age and male gender (P = 0.002 and P = 0.043, respectively). HCC occurred more frequently in patients of age a parts per thousand yen30 years even with early stage than in patients of age < 30 years (P = 0.031). Severe reddish markings, a laparoscopic finding of widespread parenchymal destruction, were highly associated with HCC development in patients of age a parts per thousand yen30 years at diagnosis (odds ratio = 1.67, P = 0.034), while histological activity grade and ALT level were not (P = 0.075 and P = 0.69, respectively). HCC development is associated with older age, male gender, and liver cirrhosis. Reddish markings, rather than histological activity or ALT level, can be useful to predict HCC for HBV patients of age a parts per thousand yen30 years

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). Mitochondrial dysfunction appears to play a role in the progression from simple steatosis to NASH. L-carnitine (L-b-hydroxy-g-N-trimethylaminobutyric acid), an essential nutrient that converts fat into energy in mitochondria, has been shown to ameliorate liver damage. The aim of the present study was to explore the preventive and therapeutic effect of L-carnitine in NASH model mice. Eight-week-old male STAM mice, a NASH-cirrhosis-hepatocarcinogenic model, were divided into 3 experimental groups and fed as follows: 1) high-fat diet (HFD) (control group); 2) HFD mixed with 0.28% L-carnitine (L-carnitine group); and 3) HFD mixed with 0.01% alpha-tocopherol (alpha-tocopherol group). After 4 or 8 weeks, mice were sacrificed. Blood samples and livers were collected, and hepatic tumors were counted and measured. Livers were subjected to histological study, immunohistochemical staining of 4-hydroxynonenal and ferritin, determination of 8-OHdG levels, mRNA and protein expressions for multiple genes, and metabolomic analysis. The intestinal microbiome was also analyzed. L-carnitine increased hepatic expression of genes related to long-chain fatty acid transport, mitochondrial beta-oxidation, and antioxidant enzymes following suppression of hepatic oxidative stress markers and inflammatory cytokines in NASH, and mice treated with L-carnitine developed fewer liver tumors. Although alpha-tocopherol resulted in NASH improvement in the same manner as L-carnitine, it increased periodontitis-related microbiotic changes and hepatic iron transport-related gene expression and led to less effective for anti-hepatocarcinogenesis. Conclusion: L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model by upregulating the mitochondrial beta-oxidation and redox system

Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis

A predictive marker of the rapid progression to hepatic failure is desired for patients with asymptomatic primary biliary cirrhosis (aPBC). We performed a systematic cohort analysis of 101 patients diagnosed as having aPBC and the rapid progression to liver failure in some, by focusing on cholestasis. Cholestasis was assessed by aberrant keratin7 (K-7) expressions in the patientsʼ hepatocytes. Intralobular expressions of K-7 were found in 9 of the 101 patients. The grades of K-7 expression were significantly associated with the levels of alanine aminotransferase, alkaline phosphatase, and total bilirubin at the time of diagnosis, but not with bile duct loss or cholestasis. Stepwise logistic regression analysis revealed that high grades of K-7 expression correlated positively with high levels of total bilirubin. During the follow-up period, 8 patients developed jaundice, and the mean period until the development of jaundice was 5.2 years. The proportional hazards models for the risk of developing jaundice identified a high grade of aberrant K-7 expression in hepatocytes as the only significant risk factor. Aberrant K-7 expression in hepatocytes can be used as an additional marker to predict rapid progression to liver failure in patients with aPBC at the time of diagnosis

The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis

The single nucleotide polymorphism (SNP) rs738409 in patatin-like phospholipase domain-containing protein 3 (PNPLA3) is associated with hepatic fat accumulation and disease progression in patients with non-alcoholic fatty liver disease and alcoholic liver disease (ALD). This study was conducted to determine whether PNPLA3 rs738409 SNPs affect development and prognosis of hepatocellular carcinoma (HCC) in patients with various liver diseases. We enrolled 638 consecutive Japanese patients newly diagnosed with HCC between 2001 and 2010: 72 patients with hepatitis B virus (HBV), 462 with hepatitis C virus (HCV), and 104 with non-B non-C (NBNC). NBNC patients exhibited large tumors of advanced TNM stages at HCC diagnosis, and had significantly poorer prognosis than HBV or HCV patients (P < 0.001 and < 0.001, respectively; log-rank test). The G/G genotype of PNPLA3 rs738409 SNP had significantly higher distribution in NBNC patients (P < 0.001) and was significantly associated with higher body mass index (BMI) and an increased aspartate aminotransferase to platelet ratio index. No significant differences were observed in survival with differences in PNPLA3 SNP genotypes among the patients, although ALD patients with the G/G genotype of PNPLA3 SNP and low BMI had significantly poorer survival than those with high BMI (P = 0.028). The G/G genotype of PNPLA3 rs738409 SNP was more frequently distributed, and associated with BMI and fibrosis among NBNC-HCC patients but not among HBV or HCV patients. These genotypes might affect HCC prognosis in ALD patients, but not in HBV, HCV, or NAFLD patients